Evidence memo / Reproductive & endocrine

Felypressin

Also: Octapressin · Phe2-Lys8-vasopressin · vasopressin analog vasoconstrictor

Felypressin (Octapressin) is a vasopressin-like peptide used as a vasoconstrictor in dental local anesthetics, mixed with prilocaine. It tightens nearby blood vessels to make the numbing last longer and reduce bleeding, serving as an alternative to adrenaline (epinephrine) when that is best avoided. It is widely used in dentistry in many countries but is not FDA-approved in the US. The Watchlist boundary is its narrow dental-anesthetic role, and cautions in serious heart disease and pregnancy.

Approved for specific usesApproved specific use

The verdict

Our read at a glance.

Whether felypressin is understood as a dental local-anesthetic vasoconstrictor (an epinephrine alternative), rather than a systemic vasopressin drug, and whether its heart and pregnancy cautions are kept in view.

The signal
Dental pharmacology studies show felypressin, combined with prilocaine, provides effective local anesthesia and causes smaller heart-rate and blood-pressure changes than adrenaline, though it is a somewhat weaker vasoconstrictor for controlling bleeding. It is an established option in many countries.
The unknown
Its best role for specific patients (for example, those for whom adrenaline is undesirable), and how to weigh its own cardiovascular cautions at higher doses.
Our read
A practical niche peptide: a vasopressin-like vasoconstrictor that lets dental anesthetics work without adrenaline's heart stimulation. It is effective and well-established in many countries (though not FDA-approved in the US), a slightly weaker vasoconstrictor than adrenaline, with its own cautions in heart disease and pregnancy. Narrow, useful, and not a systemic drug.

The mechanism

How it works.

Local anesthetics work better and longer when a vasoconstrictor is added to keep the drug from washing away in the bloodstream and to limit bleeding. The usual choice is adrenaline (epinephrine), which also stimulates the heart. Felypressin is a modified copy of the hormone vasopressin that tightens blood vessels through a different receptor (the vasopressin V1 receptor) rather than the adrenaline receptors, so it constricts local vessels with much less effect on heart rate. Mixed with the anesthetic prilocaine, it prolongs numbing and reduces bleeding; because it acts on vasopressin receptors, very high doses can also constrict the heart's own arteries and affect the uterus, which is why it is used cautiously in heart disease and avoided in pregnancy.

Safety & regulatory boundary

The consequential part.

Felypressin avoids adrenaline's heart-rate and blood-pressure spikes, but at higher doses it can constrict the heart's own arteries, so caution is advised in serious heart disease; it can also affect the uterus and is generally avoided in pregnancy. It is a component of dental local anesthetics in many countries but is not FDA-approved in the US (where adrenaline is standard). It is for dental anesthesia, not a systemic blood-pressure or hormone treatment.

What's next

What we're watching.

Comparative data in patients for whom adrenaline is best avoided, and clearer guidance on its cardiovascular cautions.

Context

Why this is discussed.

Most dental anesthetics use adrenaline to make the numbing last and to limit bleeding, but adrenaline raises heart rate and blood pressure. Felypressin is a vasopressin-like peptide used instead of adrenaline in some dental anesthetics, constricting local vessels without the same adrenaline-type heart stimulation.

The evidence base

7 cited references.

Keep reading

Related published memos.